Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2013-05-31

FDA Approved: HUMULIN R — Supplemental Application (Eli Lilly and Company)

View source ↗

Summary

The FDA approved a supplemental application for HUMULIN R (insulin human) submitted by Eli Lilly and Company.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Humulin R

Snippet

SUPPL AP for HUMULIN R (INSULIN HUMAN)